- RecruitingPHASE1, PHASE2
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
This study is testing two new medicines, BNT324 and BNT327, together for people with advanced lung cancer. It aims to see how safe and effective this combination is, helping to find the best dose.
For: Advanced Lung CancerUnited States · Australia · China - RecruitingPHASE1, PHASE2
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
This study is testing two new treatments, BNT323 and BNT327, for advanced breast cancer. It aims to find the safest and most effective dose when used together, and to see if this combination helps patients with different types of breast cancer.
For: Locally Advanced Breast Cancer · Unresectable Breast Carcinoma · Metastatic Breast CancerUnited States · Canada · China - RecruitingPHASE1, PHASE2
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
This study is testing new combination medicines, BNT326 and BNT327, for people with advanced non-small cell lung cancer. It aims to find a safe dose and see how well they work, both for those who've had previous treatments and those who haven't.
For: Non-small Cell Lung CancerUnited States · Australia · China